WallStreetZenWallStreetZen

How to Buy Design Therapeutics Stock

Design Therapeutics Inc

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions.

Design Therapeutics stock last closed at $3.62, up 2.84% from the previous day, and has decreased 48.73% in one year. It has underperformed other stocks in the Biotechnology industry by 0.28 percentage points. Design Therapeutics stock is currently +86.6% from its 52-week low of $1.94, and -57.26% from its 52-week high of $8.47.

At the moment, there are 56.49M shares of DSGN outstanding. The market capitalization of DSGN is $204.51M. In the past 24 hours, 144,926 DSGN shares were traded.

How to Buy Design Therapeutics Stock

Wondering how to invest in Design Therapeutics stock? Here's how.
  1. Figure out where to buy Design Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Design Therapeutics stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Put funds into your brokerage account: Pick your payment method and add your details.
  4. Research Design Therapeutics stock: The Design Therapeutics ticker symbol is DSGN. Is Design Therapeutics stock a good investment? Should you buy shares of DSGN? How do DSGN's underlying business fundamentals look? Do top analysts think Design Therapeutics is a good buy? Why has DSGN's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if DSGN is a good stock to buy).
  5. Place your DSGN buy order: Decide if you will purchase DSGN shares at the current market price or use a limit order to purchase DSGN shares at a given price.
  6. Monitor your DSGN position: Create a watchlist to the latest updates on your investment in Design Therapeutics shares.

Step 1: Figure out where to buy Design Therapeutics stock

You will need a brokerage account in order to access the NASDAQ market and buy DSGN shares.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global financial markets: From Technology to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked your brokerage, it's time to fill out some personal info so you are able to buy DSGN stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to create your new trading account.
  1. Submit your details by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have finished signing up on the highest rated stock app, you need to deposit funds:

Check out this video walkthrough if you need help transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Design Therapeutics stock

Once you have chosen the best place to buy Design Therapeutics stock, it's critical to evaluate their stock prior to investing, so you can understand the risk and upside.

Design Therapeutics shares at a glance

DSGN Price
$3.62
1w %
-0.82%
1y %
-48.73%
5y %
N/A
P/E
-3.04x
P/B
0.74x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$66.86M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$204.51M
Next Earnings
Jun 13, 2024
Next Dividend
N/A

DSGN Fundamentals

WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on DSGN's stock page.

How is DSGN stock valued?

Analysts use many financial metrics, analyses, models, and charts to gauge DSGN's fair value.

Using relative valuations measures:

  • DSGN may be undervalued based on its P/B ratio of 0.74x, relative to Biotechnology industry P/B ratio of 6.02x

You can access more valuation analysis on DSGN's stock here.

DSGN Financial Health

Positive Health Checks:

  • DSGN has a low debt to equity ratio of 0.04.
  • There are more short-term assets than long-term liabilities on the DSGN balance sheet.
  • DSGN has cash burn of 58816000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the DSGN balance sheet.
  • DSGN has $281.80M in cash and short term investments. This is enough to cover its annual cash burn of $58.82M.

Is DSGN stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 2 Equities analysts who give forecasts on DSGN, the consensus analyst rating on DSGN is a Hold

It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are forecasting on the Design Therapeutics stock forecast page.

Metrics for Advanced DSGN Traders

SMA10
3.7
SMA20
3.73
SMA50
3.33
SMA100
2.9
SMA200
3.1
MACD
0.08
MACD Signal
0.13
MACD Histogram
-0.05
RSI
50.6
Stochastic %K
19.84
Stochastic %D
31.65
StochRSI %K
10.75
StochRSI %D
16.37

How is DSGN performing as a company?

Last year, DSGN revenue was $0.00. In the last 4 year, DSGN's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 28.49%.

Find out more about DSGN's earnings and revenue performance here.

Who is buying/selling DSGN?

In the last year, insiders at DSGN have bought more shares than they have sold.

Heather A. Berger, Director of DSGN, was the latest DSGN insider to buy. They bought $4,865.90 worth of DSGN shares on Mar 25, 2024.

Dig into more about who owns DSGN shares here.

Does DSGN stock generate passive income?

No, Design Therapeutics doesn't provide an income stream by paying out dividends.

Get analysis from other traders

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Place your DSGN buy order

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a particular price limit, place a limit order.

Click the Open button and eToro will place the order.

If you want more help investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Monitor your DSGN position

Now that you own some DSGN stock, you'll want to stay up-to-date on your new stock purchase.

Add DSGN to a watchlist to keep tabs on your DSGN stock.

DSGN Feed

How to Buy Stock in Design Therapeutics

To reiterate, here are the 6 steps for buying Design Therapeutics stock:

  1. Figure out where to buy Design Therapeutics stock
  2. Create your brokerage account
  3. Put funds into your brokerage account
  4. Research Design Therapeutics stock
  5. Place your DSGN buy order
  6. Monitor your DSGN position

If you need a place to buy stocks, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep an eye on your investment in Design Therapeutics, click the button below.

NASDAQ: DSGN
$3.62+0.10 (+2.84%)
Updated May 1, 2024
Open eToro Account
NASDAQ: DSGN
$3.62+0.10 (+2.84%)
Updated May 1, 2024
Open eToro Account

FAQ

How much does it cost to buy one Design Therapeutics share?

As of May 1, 2024, it costs $3.62 to buy one share of Design Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.276 shares of DSGN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Design Therapeutics stock?

According to 2 Wall Street analysts who monitor Design Therapeutics, their consensus recommendation is to hold Design Therapeutics stock.

What is the best way to buy Design Therapeutics stock?

One way to place an order for Design Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.